Haematology Practice Review, Issue 47
In this issue:
Patient blood management guidelines for adults with critical bleeding
Using COVID-19 therapeutics in patients with haematological malignancies
BSH guideline: Managing newly diagnosed LBCL
BSH Good Practice Paper: Diagnosing and managing SMM
Treating BCR/ABL-positive CML in children
Predicting the histology of relapsed or refractory lymphoma using FDG-PET
CAR-T recipients report higher rates of ‘potentially serious’ toxicities
Erwinase (crisantaspase) approved for use
Genetic testing for variants associated with haematological malignancies
PBS update: Ibrutinib (Imbruvica)
New AusPAR for avatrombopag (Doptelet)
New AusPAR for tafasitamab (Minjuvi)
Hypertension treatment in patients receiving ibrutinib
Risk of venous thromboembolic events after surgery for cancer
Death from MCL limits sequential therapy, particularly after first relapse
COVID-19 resources
Conferences, workshops and CPD
Expert contributor
Professor Jeff Szer
Professor Jeff Szer AM (@marrow), is a member of the Clinical Haematology team at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital. He is also Director of the Western and Central Melbourne Integrated Cancer Service and outgoing President of the World Marrow Donor Association. He established the first adult bone marrow transplant centre in […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.